clopidogrel and Heart Valve Diseases

clopidogrel has been researched along with Heart Valve Diseases in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Berdibekov, BS; Bulaeva, NI; Golukhova, EZ; Kubova, MC; Ruzina, EV1
Baber, U; Dangas, GD; Giustino, G; Guimarães, AH; Hemmrich, M; Mehran, R; Thomitzek, K; Tijssen, J; Valgimigli, M; van Es, GA; Volkl, AA; Vranckx, P; Welsh, RC; Wildgoose, P; Windecker, S; Zazula, A1
Arumugham, S; Payanam Ramachandra, U; Shenoy, SJ1
Resnic, FS; Sparling, JM1
Gendlin, GE; Storozhakov, GI; Tronina, OA1
Barry, WH; Coletti, AT; Jessup, DB; Muhlestein, JB; Shean, FC; Whisenant, BK1
García-Rinaldi, R1

Reviews

1 review(s) available for clopidogrel and Heart Valve Diseases

ArticleYear
[Antithrombotic therapy in patients with prosthetic heart valves].
    Kardiologiia, 2010, Volume: 50, Issue:9

    Topics: Anticoagulants; Aspirin; Blood Coagulation Tests; Clopidogrel; Drug Monitoring; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Monitoring, Physiologic; Platelet Aggregation Inhibitors; Prognosis; Thromboembolism; Ticlopidine; Warfarin

2010

Trials

1 trial(s) available for clopidogrel and Heart Valve Diseases

ArticleYear
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
    American heart journal, 2017, Volume: 184

    Topics: Aortic Valve Stenosis; Aspirin; Cardiovascular Diseases; Cause of Death; Clopidogrel; Drug Therapy, Combination; Embolism; Factor Xa Inhibitors; Heart Valve Diseases; Humans; Mortality; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Care; Pulmonary Embolism; Rivaroxaban; Stroke; Thrombosis; Ticlopidine; Transcatheter Aortic Valve Replacement; Venous Thrombosis

2017

Other Studies

6 other study(ies) available for clopidogrel and Heart Valve Diseases

ArticleYear
[Comparison of Various Regimens of Antithrombotic Therapy in Patients With Valvular Heart Disease and Coronary Artery Disease After Surgical and Interventional Interventions].
    Kardiologiia, 2023, Jul-28, Volume: 63, Issue:7

    Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Disease; Female; Fibrinolytic Agents; Heart Valve Diseases; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Thromboembolism; Treatment Outcome

2023
Improved Pig Model to Evaluate Heart Valve Thrombosis.
    The Journal of heart valve disease, 2016, Volume: 25, Issue:5

    Topics: Animals; Aspirin; Blood Coagulation; Blood Platelets; Clopidogrel; Disease Models, Animal; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Swine; Thrombosis; Ticlopidine

2016
Testing a no-warfarin heart valve.
    Harvard heart letter : from Harvard Medical School, 2006, Volume: 16, Issue:8

    Topics: Anticoagulants; Aspirin; Clopidogrel; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin

2006
Highlights from Transcatheter Cardiovascular Therapeutics 2009: San Francisco, California, September 21 to 25, 2009.
    The Journal of thoracic and cardiovascular surgery, 2010, Volume: 139, Issue:2

    Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Cardiac Surgical Procedures; Clinical Trials as Topic; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Heart Valve Diseases; Humans; Myocardial Revascularization; Platelet Aggregation Inhibitors; Retreatment; Stents; Ticlopidine; Treatment Outcome

2010
Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2003, Volume: 60, Issue:2

    Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Atrial Fibrillation; Cardiac Catheterization; Cerebrovascular Disorders; Clopidogrel; Coronary Angiography; Coronary Disease; Equipment Design; Feasibility Studies; Female; Follow-Up Studies; Heart Failure; Heart Septal Defects, Atrial; Heart Valve Diseases; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine; Treatment Outcome; Venous Thrombosis; Warfarin

2003
Clopidogrel-aspirin inhibit the thrombogenicity of St. Jude mechanical aortic prostheses.
    The Annals of thoracic surgery, 2006, Volume: 81, Issue:2

    Topics: Aspirin; Clopidogrel; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Patient Selection; Platelet Aggregation Inhibitors; Postoperative Complications; Thromboembolism; Ticlopidine

2006